Regulatory roles of micro-RNAs in T cell autoimmunity

References

• Alevizos I, Illei GG. (2010a). MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol, 6, 391–98.
   PubMed Web of Science ®Google Scholar
• Alevizos I, Illei GG. (2010b). MicroRNAs in Sjögren’s syndrome as a prototypic autoimmune disease. Autoimmun Rev, 9, 618–21.
   PubMed Web of Science ®Google Scholar
• Alsaleh G, Suffert G, Semaan N, et al. (2009). Bruton’s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol, 182, 5088–97.
   PubMed Web of Science ®Google Scholar
• Amado T, Schmolka N, Metwally H, et al. (2015). Cross‐regulation between cytokine and microRNA pathways in T cells. Eur J Immunol, 45, 1584–1595.
   PubMed Web of Science ®Google Scholar
• Benderska N, Dittrich A-L, Knaup S, et al. (2015). miRNA-26b overexpression in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis, 21, 2039.
   PubMed Web of Science ®Google Scholar
• Bhaumik D, Scott G, Schokrpur S, et al. (2008). Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene, 27, 5643–47.
   PubMed Web of Science ®Google Scholar
• Boldin M, Chang K. (2006). NF—kappaB· dependent induction of microRNA miR 一 146. an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci US, 103, 12481–86.
   PubMed Web of Science ®Google Scholar
• Boldin MP, Taganov KD, Rao DS, et al. (2011). miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med, 208, 1189–201.
   PubMed Web of Science ®Google Scholar
• Carissimi C, Fulci V, Macino G. (2009). MicroRNAs: novel regulators of immunity. Autoimmun Rev, 8, 520–24.
   PubMed Web of Science ®Google Scholar
• Ceribelli A, Yao B, Dominguez-Gutierrez PR, et al. (2011). MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther, 13, 229.
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Voulgari P, Georgiou I, Drosos A. (2010). The role of microRNA‐146a (miR‐146a) and its target IL‐1R‐associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol, 71, 382–85.
   PubMed Web of Science ®Google Scholar
• Chong MM, Rasmussen JP, Rudensky AY, Littman DR. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med, 205, 2005–17.
   PubMed Web of Science ®Google Scholar
• Churov AV, Oleinik EK, Knip M. (2015). MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev, 14, 1029–37.
   PubMed Web of Science ®Google Scholar
• Cox MB, Cairns MJ, Gandhi KS, et al. (2010). MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PloS One, 5, e12132.
   PubMed Web of Science ®Google Scholar
• De La Torre NG, Fernández-Durango R, Gómez R, et al. (2015). Expression of angiogenic MicroRNAs in endothelial progenitor cells from type 1 diabetic patients with and without diabetic retinopathy MicroRNA expression in EPCs from DM1 patients. Invest Ophthalmol Vis Sci, 56, 4090–98.
   PubMed Web of Science ®Google Scholar
• Demircan K, Yasar Z, Yüksel S, et al. (2014). AB0067 IL-17F gene polymorphism correlated with longer disease duration of rheumatoid arthritis patients. Ann Rheum Dis, 73, 826.
   Web of Science ®Google Scholar
• Deng X, Su Y, Wu H, et al. (2015). The role of microRNAs in autoimmune diseases with skin involvement. Scand J Immunol, 81, 153–65.
   PubMed Web of Science ®Google Scholar
• Ding S, Liang Y, Zhao M, et al. (2012). Decreased microRNA‐142‐3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum, 64, 2953–63.
   PubMed Web of Science ®Google Scholar
• Du C, Liu C, Kang J, et al. (2009). MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol, 10, 1252–59.
   PubMed Web of Science ®Google Scholar
• Ebert PJ, Jiang S, Xie J, et al. (2009). An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol, 10, 1162–69.
   PubMed Web of Science ®Google Scholar
• Escobar TM, Kanellopoulou C, Kugler DG, et al. (2014). miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity, 40, 865–79.
   PubMed Web of Science ®Google Scholar
• Fox R, Kang H-I. (1992). Pathogenesis of Sjogren’s syndrome. Rheum Dis Clin North Am, 18, 517–38.
   PubMed Web of Science ®Google Scholar
• Fu G, Rybakin V, Brzostek J, et al. (2014). Fine-tuning T cell receptor signaling to control T cell development. Trends Immunol, 35, 311–18.
   PubMed Web of Science ®Google Scholar
• Fulci V, Scappucci G, Sebastiani GD, et al. (2010). miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol, 71, 206–11.
   PubMed Web of Science ®Google Scholar
• Gandhi R. (2015). miRNA in multiple sclerosis: search for novel biomarkers. Mult Scler J, 21, 1095–1103.
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. (2014). Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol, 15, 509–24.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, et al. (2005). A microRNA polycistron as a potential human oncogene. Nature, 435, 828–33.
   PubMed Web of Science ®Google Scholar
• Hezova R, Slaby O, Faltejskova P, et al. (2010). microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol, 260, 70–74.
   PubMed Web of Science ®Google Scholar
• Hickson LJ, Crowson CS, Gabriel SE, et al. (2014). Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis, 63, 206–13.
   PubMed Web of Science ®Google Scholar
• Hillen M, Blokland S, Chouri E, et al. (2016). THU0268 decreased expression of MIR-130A and MIR-708 in type-1 classical dendritic cells of Sjögren’s syndrome patients indicates their dysregulation. Ann Rheum Dis, 75, 284.
   Web of Science ®Google Scholar
• Holmdahl R, Malmström V, Burkhardt H. (2014). Autoimmune priming, tissue attack and chronic inflammation—the three stages of rheumatoid arthritis. Eur J Immunol, 44, 1593–99.
   PubMed Web of Science ®Google Scholar
• Honardoost MA, Kiani-Esfahani A, Ghaedi K, et al. (2014). miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing–remitting multiple sclerosis. Gene, 544, 128–33.
   PubMed Web of Science ®Google Scholar
• Huffaker TB, O’Connell RM. (2015). miR-155-SOCS1 as a functional axis: satisfying the burden of proof. Immunity, 43, 3–4.
   PubMed Web of Science ®Google Scholar
• Jernås M, Malmeström C, Axelsson M, et al. (2013). MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol, 14, 1.
   PubMed Web of Science ®Google Scholar
• Ji Y, Wrzesinski C, Yu Z, et al. (2015). miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. Proc Natl Acad Sci, 112, 476–81.
   PubMed Web of Science ®Google Scholar
• Jindra PT, Bagley J, Godwin JG, Iacomini J. (2010). Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol, 185, 990–97.
   PubMed Web of Science ®Google Scholar
• Junker A, Krumbholz M, Eisele S, et al. (2009). MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain, 132, 3342–52.
   PubMed Web of Science ®Google Scholar
• Kaga H, Komatsuda A, Omokawa A, et al. (2015). Down-regulated expression of miR-155, miR-17, and miR-181b, and up-regulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE. Mod Rheumatol, 25, 865–870.
   Google Scholar
• Kanellopoulou C, Muljo SA, Kung AL, et al. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev, 19, 489–501.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Lange J, et al. (2009). Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PloS One, 4, e7440.
   Web of Science ®Google Scholar
• Kelly CA, Saravanan V, Nisar M, et al. (2014). Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study. Rheumatology, 53, 1676–82.
   PubMed Web of Science ®Google Scholar
• Kim KM, Park SJ, Jung SH, et al. (2012). miR‐182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Mineral Res, 27, 1669–79.
   PubMed Web of Science ®Google Scholar
• Kohlhaas S, Garden OA, Scudamore C, et al. (2009). Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol, 182, 2578–82.
   PubMed Web of Science ®Google Scholar
• Lai M, Xiao C. (2015). Functional interactions among members of the miR-17–92 cluster in lymphocyte development, differentiation and malignant transformation. Int Immunopharmacol, 28, 854–858.
   Web of Science ®Google Scholar
• Lamers I, Kelchtermans S, Baert I, et al. (2014). Upper limb assessment in multiple sclerosis: a systematic review of outcome measures and their psychometric properties. Arch Phys Med Rehab, 95, 1184–1200.
   Google Scholar
• Lawrie CH, Soneji S, Marafioti T, et al. (2007). Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma. Int J Cancer, 121, 1156–61.
   PubMed Web of Science ®Google Scholar
• Li H, Xie H, Liu W, et al. (2009). A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest, 119, 3666.
   PubMed Web of Science ®Google Scholar
• Li L, Chen XP, Li YJ. (2010). MicroRNA‐146a and Human Disease. Scand J Immunol, 71, 227–31.
   PubMed Web of Science ®Google Scholar
• Lindberg R, Hoffmann F, Kuhle J, Kappos L. (2010a). Circulating microRNAs as indicators for disease course of multiple sclerosis. Mult. Scler, 16, S41–S196.
   Google Scholar
• Lindberg RL, Hoffmann F, Mehling M, et al. (2010b). Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients. Eur J Immunol, 40, 888–98.
   PubMed Web of Science ®Google Scholar
• Liston A, Lu L-F, O’Carroll D, et al. (2008). Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med, 205, 1993–2004.
   PubMed Web of Science ®Google Scholar
• Lu L-F, Boldin MP, Chaudhry A, et al. (2010). Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell, 142, 914–29.
   PubMed Web of Science ®Google Scholar
• Lu L-F, Gasteiger G, Yu I-S, et al. (2015). A single miRNA-mRNA interaction affects the immune response in a context-and cell-type-specific manner. Immunity, 43, 52–64.
   PubMed Web of Science ®Google Scholar
• Lu L-F, Thai T-H, Calado DP, et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity, 30, 80–91.
   PubMed Web of Science ®Google Scholar
• Lu MC, Lai NS, Chen HC, et al. (2013). Decreased microRNA (miR)‐145 and increased miR‐224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol, 171, 91–99.
   PubMed Web of Science ®Google Scholar
• Luo X, Yang W, Ye D-Q, et al. (2011). A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS genetics, 7, e1002128.
   Google Scholar
• Lv M, Zhang X, Jia H, et al. (2012). An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia, 26, 769–77.
   PubMed Web of Science ®Google Scholar
• Magni S, Comani GB, Elli L, et al. (2014). miRNAs affect the expression of innate and adaptive immunity proteins in celiac disease. Am J Gastroenterol, 109, 1662.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Shir Jang S, Baradaran B. (2016). Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA). Artificial Cells, Nanomedicine, Biotechnol, 44, 1589–96.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Shotorbani SS, Baradaran B. (2014). RNA interference and its role in cancer therapy. Adv Phar Bull, 4, 313.
   PubMedGoogle Scholar
• Mehta A, Baltimore D. (2016). MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol, 16, 279–94.
   PubMed Web of Science ®Google Scholar
• Melnik BC, John SM, Schmitz G. (2014). Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy. J Transl Med, 12, 43.
   PubMed Web of Science ®Google Scholar
• Meng X, Kaufmann S. (2014). Bim regulation miRrors microRNA 17∼ 92 cluster expression in endothelial cells in vivo. Cell Death Differ, 21, 1665–66.
   PubMed Web of Science ®Google Scholar
• Miyaki S, Nakasa T, Otsuki S, et al. (2009). MicroRNA‐140 is expressed in differentiated human articular chondrocytes and modulates interleukin‐1 responses. Arthritis Rheum, 60, 2723–30.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Mansoori B, Baradaran B. (2016). The role of microRNAs in colorectal cancer. Biomed Pharmacother, 84, 705–13.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Mansoori B, Baradaran B. (2017). Regulation of miRNAs by herbal medicine: an emerging field in cancer therapies. Biomed Pharmacother, 86, 262–70.
   PubMed Web of Science ®Google Scholar
• Mraz M, Chen L, Rassenti LZ, et al. (2014). miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood, 124, 84–95.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Nakasa T, Mochizuki Y, et al. (2009). Induction of apoptosis in the synovium of mice with autoantibody‐mediated arthritis by the intraarticular injection of double‐stranded MicroRNA‐15a. Arthritis Rheum, 60, 2677–83.
   PubMed Web of Science ®Google Scholar
• Nakamachi Y, Kawano S, Takenokuchi M, et al. (2009). MicroRNA‐124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast‐like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum, 60, 1294–304.
   PubMed Web of Science ®Google Scholar
• Nakasa T, Miyaki S, Okubo A, et al. (2008). Expression of microRNA‐146 in rheumatoid arthritis synovial tissue. Arthritis Rheum, 58, 1284–92.
   PubMed Web of Science ®Google Scholar
• Nakasa T, Shibuya H, Nagata Y, et al. (2011). The inhibitory effect of microRNA‐146a expression on bone destruction in collagen‐induced arthritis. Arthritis Rheum, 63, 1582–90.
   PubMed Web of Science ®Google Scholar
• Niimoto T, Nakasa T, Ishikawa M, et al. (2010). MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord, 11, 209.
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Baltimore D. (2012). microRNA regulation of inflammatory responses. Annu Rev Immunol, 30, 295–312.
   PubMed Web of Science ®Google Scholar
• O’connell RM, Rao DS, Chaudhuri AA, Baltimore D. (2010). Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol, 10, 111–22.
   PubMed Web of Science ®Google Scholar
• Oertli M, Engler DB, Kohler E, et al. (2011). MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol, 187, 3578–86.
   PubMed Web of Science ®Google Scholar
• Pan W, Zhu S, Yuan M, et al. (2010). MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol, 184, 6773–81.
   PubMed Web of Science ®Google Scholar
• Paraskevi A, Theodoropoulos G, Papaconstantinou I, et al. (2012). Circulating MicroRNA in inflammatory bowel disease. J Crohn’s Colitis, 6, 900–04.
   Google Scholar
• Pauley KM, Cha S, Chan EK. (2009). MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32, 189–94.
   PubMed Web of Science ®Google Scholar
• Pauley KM, Satoh M, Chan AL, et al. (2008). Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther, 10, R101.
   PubMed Web of Science ®Google Scholar
• Perez P, Teos L, Tandon M, et al. (2015). Downregulation of Microrna-183 in Sjögren’s syndrome minor salivary glands; implications in the control of ezrin expression and salivary gland function. Scand J Immunol, 81, 426.
   Web of Science ®Google Scholar
• Quinn SR, O’Neill LA. (2011). A trio of microRNAs that control Toll-like receptor signalling. Int Immunol, 23, 421–25.
   PubMed Web of Science ®Google Scholar
• Rao DS, O’Connell RM, Chaudhuri AA, et al. (2010). MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity, 33, 48–59.
   PubMed Web of Science ®Google Scholar
• Regev K, Healy B, Paul A, et al. (2016). A comprehensive evaluation of serum microRNAs as potential biomarkers in multiple sclerosis (P1. 390). Neurology, 86, 390.
   Google Scholar
• Richmond TK, Tili E, Chiabai M, et al. (2015). Functional interaction of Mir-155, a pro-inflammatory microRNA, and quaking in the innate immune response. J Allergy Clin Immunol, 135, AB97.
   Web of Science ®Google Scholar
• Rodriguez A, Vigorito E, Clare S, et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science, 316, 608–11.
   PubMed Web of Science ®Google Scholar
• Runtsch MC, Hu R, Alexander M, et al. (2015). MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget, 6, 28556.
   PubMed Web of Science ®Google Scholar
• Sernyak MJ, Leslie DL, Alarcon RD, et al. (2002). Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry, 159, 561–566.
   PubMed Web of Science ®Google Scholar
• Severin ME, Lee PW, Liu Y, et al. (2016). MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis. Brain: aww084.
   Google Scholar
• Shi H, Zheng LY, Zhang P, Yu CQ. (2014). miR‐146a and miR‐155 expression in PBMCs from patients with Sjögren’s syndrome. J Oral Pathol Med, 43, 792–97.
   PubMed Web of Science ®Google Scholar
• Simpson LJ, Ansel KM. (2015). MicroRNA regulation of lymphocyte tolerance and autoimmunity. J Clin Investig, 125, 2242.
   PubMed Web of Science ®Google Scholar
• Simpson N, Gatenby PA, Wilson A, et al. (2010). Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum, 62, 234–44.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Ospelt C, Karouzakis E, et al. (2011). Altered expression of microRNA‐203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum, 63, 373–81.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Pedrioli DML, Brentano F, et al. (2008). Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum, 58, 1001–09.
   PubMed Web of Science ®Google Scholar
• Stittrich A-B, Haftmann C, Sgouroudis E, et al. (2010). The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol, 11, 1057–62.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kanno T, Nakayamada S, et al. (2012). TGF-[beta] and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat Immunol, 13, 587–95.
   PubMed Web of Science ®Google Scholar
• Tang X, Tang R, Xu Y, et al. (2014). MicroRNA networks in regulatory T cells. J Physiol Biochem, 70, 869–75.
   PubMed Web of Science ®Google Scholar
• Tecchio C, Micheletti A, Cassatella MA. (2014). Neutrophil-derived cytokines: facts beyond expression. Front Immunol, 5, 1–7.
   PubMed Web of Science ®Google Scholar
• Thamilarasan M, Koczan D, Hecker M, et al. (2012). MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev, 11, 174–79.
   PubMed Web of Science ®Google Scholar
• Tomankova T, Petrek M, Gallo J, Kriegova E. (2012). MicroRNAs: emerging regulators of immune‐mediated diseases. Scand J Immunol, 75, 129–41.
   PubMed Web of Science ®Google Scholar
• Van Keimpema M, Grüneberg LJ, Mokry M, et al. (2014). FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells. Blood, 124, 3431.
   PubMed Web of Science ®Google Scholar
• Vigorito E, Perks KL, Abreu-Goodger C, et al. (2007). microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity, 27, 847–59.
   PubMed Web of Science ®Google Scholar
• Wissink EM, Smith NL, Spektor R, et al. (2015). MicroRNAs and their targets are differentially regulated in adult and neonatal mouse CD8+ T cells. Genetics: Genetics, 115, 179176.
   Google Scholar
• Yu D. (2014). MicroRNAs in Tfh cells: micromanaging inflammaging. Immunity, 41, 509–11.
   PubMed Web of Science ®Google Scholar
• Yu D, Tan AH-M, Hu X, et al. (2007). Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature, 450, 299–303.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Mayr M. (2015). Sweet dicer impairment of Micro-RNA processing by diabetes. Circ Res, 117, 116–18.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin Y, Lin Y, et al. (2015). Adipose-derived mesenchymal stem cells ameliorate ulcerative colitis through miR-1236 negatively regulating the expression of retinoid-related orphan receptor gamma. DNA Cell Biol, 34, 618–25.
   PubMed Web of Science ®Google Scholar
• Zhao X, Tang Y, Qu B, et al. (2010). MicroRNA‐125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum, 62, 3425–35.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Haupt S, Kreuzer JT, et al. (2015). Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann Rheum Dis, 74, 1265–74.
   PubMed Web of Science ®Google Scholar
• Zhou X, Jeker LT, Fife BT, et al. (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med, 205, 1983–91.
   PubMed Web of Science ®Google Scholar